|
Name |
Penicisteroid B
|
Molecular Formula | C30H48O4 | |
IUPAC Name* |
[(3S,8S,9S,10R,11S,13S,14S,16S,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-3,11-dihydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-16-yl] acetate
|
|
SMILES |
C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1[C@H](C[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)O)C)OC(=O)C
|
|
InChI |
InChI=1S/C30H48O4/c1-17(2)18(3)8-9-19(4)27-26(34-20(5)31)15-24-23-11-10-21-14-22(32)12-13-29(21,6)28(23)25(33)16-30(24,27)7/h8-10,17-19,22-28,32-33H,11-16H2,1-7H3/b9-8+/t18-,19+,22-,23-,24-,25-,26-,27-,28+,29-,30-/m0/s1
|
|
InChIKey |
ASJDHPNJTXZGII-ZVMPSDJMSA-N
|
|
Synonyms |
Penicisteroid B
|
|
CAS | NA | |
PubChem CID | 139588208 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 472.7 | ALogp: | 5.9 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 66.8 | Aromatic Rings: | 4 |
Heavy Atoms: | 34 | QED Weighted: | 0.38 |
Caco-2 Permeability: | -4.687 | MDCK Permeability: | 0.00002420 |
Pgp-inhibitor: | 0.981 | Pgp-substrate: | 0.994 |
Human Intestinal Absorption (HIA): | 0.142 | 20% Bioavailability (F20%): | 0.31 |
30% Bioavailability (F30%): | 0.544 |
Blood-Brain-Barrier Penetration (BBB): | 0.598 | Plasma Protein Binding (PPB): | 88.00% |
Volume Distribution (VD): | 1.001 | Fu: | 2.99% |
CYP1A2-inhibitor: | 0.029 | CYP1A2-substrate: | 0.127 |
CYP2C19-inhibitor: | 0.017 | CYP2C19-substrate: | 0.88 |
CYP2C9-inhibitor: | 0.116 | CYP2C9-substrate: | 0.041 |
CYP2D6-inhibitor: | 0.012 | CYP2D6-substrate: | 0.051 |
CYP3A4-inhibitor: | 0.842 | CYP3A4-substrate: | 0.691 |
Clearance (CL): | 3.601 | Half-life (T1/2): | 0.132 |
hERG Blockers: | 0.11 | Human Hepatotoxicity (H-HT): | 0.309 |
Drug-inuced Liver Injury (DILI): | 0.285 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.901 | Maximum Recommended Daily Dose: | 0.959 |
Skin Sensitization: | 0.312 | Carcinogencity: | 0.172 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.017 |
Respiratory Toxicity: | 0.97 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002021 | 0.649 | D0Y7LD | 0.400 | ||||
ENC002795 | 0.635 | D0B4RU | 0.393 | ||||
ENC004758 | 0.550 | D0G5CF | 0.359 | ||||
ENC001558 | 0.550 | D0G8OC | 0.354 | ||||
ENC001846 | 0.476 | D04SFH | 0.345 | ||||
ENC003369 | 0.476 | D0K0EK | 0.336 | ||||
ENC001545 | 0.471 | D06JPB | 0.333 | ||||
ENC005012 | 0.467 | D0X7XG | 0.308 | ||||
ENC004738 | 0.445 | D06CNP | 0.296 | ||||
ENC001092 | 0.445 | D02STN | 0.285 |